loader image
Sunday, November 30, 2025
57.1 F
McAllen
- Advertisement -

Human Brains Are Getting Bigger: Could This Mean Lower Dementia Risk?

Translate to Spanish or other 102 languages!

The average human brain has been growing over the last century, according to research. Image for illustration purposes
The average human brain has been growing over the last century, according to research. Image for illustration purposes
- Advertisement -
  • Dementia is a growing problem worldwide, with numbers predicted to almost triple over the next 30 years.
  • The rise is generally attributed to the growing and aging population, but lifestyle can also contribute.
  • However, a new study suggests there may be some good news in the field of dementia.
  • It found that people’s brains have been getting larger over the past 100 years, and this increased brain reserve could, potentially, reduce the risk of age-related dementias.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/human-brains-are-getting-larger-could-this-mean-lower-dementia-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×